GL1X · GenesisL1 explorer

MolNFT v1 · #61911 · protein

Human EPHA3 kinase domain in complex with inhibitor awl-II-38.3

3DZQ · Eph receptor A3: “Human EPHA3 kinase domain in complex with inhibitor awl-II-38.3”. X-ray diffraction, 1 ligand (IFC), 1 pocket (best druggability 0.72). MolNFT v1 #61911 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3DZQ
Type
protein
Length
268 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Eph receptor A3
EC
2.7.10.1
UniProt
Q6P4R6
Ligands
IFC
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEph receptor A3 (EC 2.7.10.1)protein26840% helix, 17% strandQ6P4R6

Ligands and binding sites

  • IFC · N-[2-methyl-5-({[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]carbonyl}amino)phenyl]isoxazole-5-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12050.720.8839IFC

Compared structures

  • 3DZQ · Human EphA3 kinase domain in complex with inhibitor AWL-II-38.3 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.